BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25251578)

  • 21. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
    Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
    Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
    Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
    Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple autoimmune syndromes].
    Humbert P; Dupond JL
    Ann Med Interne (Paris); 1988; 139(3):159-68. PubMed ID: 3059902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia and risk of cancer: a population-based case-control study.
    Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
    Eur J Neurol; 2014 May; 21(5):773-8. PubMed ID: 24571170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.
    Wilson AG; Gordon C; di Giovine FS; de Vries N; van de Putte LB; Emery P; Duff GW
    Eur J Immunol; 1994 Jan; 24(1):191-5. PubMed ID: 8020556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study.
    Cui C; Longinetti E; Larsson H; Andersson J; Pawitan Y; Piehl F; Fang F
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):211-219. PubMed ID: 33331190
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity.
    Lio D; Candore G; Romano GC; D'Anna C; Gervasi F; Di Lorenzo G; Modica MA; Potestio M; Caruso C
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):217-24. PubMed ID: 9740350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
    Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
    Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families.
    Henderson RD; Bain CJ; Pender MP
    J Clin Neurosci; 2000 Sep; 7(5):434-7. PubMed ID: 10942666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A family study of the antiphospholipid syndrome associated with other autoimmune diseases.
    Dagenais P; Urowitz MB; Gladman DD; Norman CS
    J Rheumatol; 1992 Sep; 19(9):1393-6. PubMed ID: 1433007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
    Nielsen NM; Frisch M; Rostgaard K; Wohlfahrt J; Hjalgrim H; Koch-Henriksen N; Melbye M; Westergaard T
    Mult Scler; 2008 Jul; 14(6):823-9. PubMed ID: 18573841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug prescription patterns in patients with Addison's disease: a Swedish population-based cohort study.
    Björnsdottir S; Sundström A; Ludvigsson JF; Blomqvist P; Kämpe O; Bensing S
    J Clin Endocrinol Metab; 2013 May; 98(5):2009-18. PubMed ID: 23543658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA and myasthenia. Subdivision in 3 categories].
    Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
    Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study.
    Ludvigsson JF; Neovius M; Hammarström L
    J Clin Immunol; 2014 May; 34(4):444-51. PubMed ID: 24584841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
    Huang DR; Pirskanen R; Matell G; Lefvert AK
    J Neuroimmunol; 1999 Feb; 94(1-2):165-71. PubMed ID: 10376950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of virus for the induction of myasthenia gravis.
    Smith CI; Hammarström L; Berg JV
    Eur Neurol; 1978; 17(4):181-7. PubMed ID: 689042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antigens of histocompatibility in children with myasthenia gravis].
    Neretin VIa; Serova LD; Agafonov BV; Tsuman VG; Gekht BM; Sidorova OP; Nalivkin AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(7):44-8. PubMed ID: 11523395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.